glp-1 intestinal paralysis class action in kentucky OZEMPIC FEET": As drugs continue to gain popularity for weight loss, a lesser-known side effect is drawing attention from podiatrists: "Ozempic feet." Read the full story the link in our Patients Are Suing Over Alleged

Gallbladder issues in people who lose weight rapidly

Liraglutide competitors Wegovy and Ozempic are based on semaglutide and require injection once per week

The pathogenesis of sepsis is a complex cascade of numerous mediators that cause cellular dysfunction, coagulopathy, endothelial dysfunction and changes in the cardiovascular system

A recent University College London research estimates that 1.6 million adults in England, Wales and Scotland used GLP-1s, such as semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro), between early 2024 and early 2025, to lose weight.

So, why are so many patients deciding to rewrite the prescription rules

Almost all included studies did not have respiratory diseases as a primary outcome, and these outcomes were derived from adverse event reports while not detecting changes in lung function